NL - Forbion and Inventages invest EUR 2.5m in AM-Pharma

Forbion Capital Partners and Inventages Venture Capital have invested EUR 2.5m in their portfolio company AM-Pharma, a Dutch biopharmaceuticals business. The investment will be followed by a Series-C financing round, for which the company is in discussion with European and American investors. The existing investors will contribute to the upcoming round as well, which will close before the end of this year.